Alayna Checkley
Medical · Clinton, UTNPI 1508380858
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,596 of the $3,396 with a category attached, or 76.4%. 26 manufacturers reported payments, led by Biohaven Pharmaceuticals, Inc. at 30.4% of the total. Reporting peaked in 2021 at $1,436 and has fallen 67.5% since, to $466 in 2025.
Across 155 payments — averaging $21.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$1K
- AbbVie$489
- Collegium Pharmaceutical, Inc.$393
- Teva Pharmaceuticals USA, Inc.$192
- Azurity Pharmaceuticals, Inc.$146
- Pfizer$142
- plus $1K from 20 others
What the payments were for
- Consulting fees$80024%
- Food & beverage$2,59676%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 13 | $1,033 |
| AbbVie(2 entities) | 30 | $489 |
| Collegium Pharmaceutical, Inc. | 29 | $393 |
| Teva Pharmaceuticals USA, Inc. | 12 | $192 |
| Azurity Pharmaceuticals, Inc. | 9 | $146 |
| Pfizer | 7 | $142 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $119 |
| Nevro Corp. | 4 | $114 |
| Arbor Pharmaceuticals, Inc. | 6 | $81 |
| Lilly USA, LLC | 4 | $70 |
| Vertex | 3 | $61 |
| Lundbeck LLC | 3 | $57 |
| Averitas Pharma Inc. | 3 | $57 |
| Ferring Pharmaceuticals Inc. | 4 | $56 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $55 |
| GRT US Holding, Inc. | 3 | $48 |
| Globus Medical | 1 | $45 |
| Upsher-smith Laboratories LLC | 3 | $43 |
| Almatica Pharma LLC | 2 | $39 |
| Scilex Pharmaceuticals Inc. | 2 | $30 |
| Biodelivery Sciences International, Inc. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Boston Scientific | 1 | $22 |
| SPR Therapeutics, Inc | 1 | $18 |
| Amgen | 1 | $18 |
| Medtronic | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$800
How this compares
$3,396 in reported general payments places this provider in the 80th percentile of 263 medical providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 22 | $29,304 |
| Buprenorphine | 58 | $23,268 |
| BelbucaBuprenorphine Hcl | 16 | $21,855 |
| OxycontinOxycodone Hcl | 11 | $10,796 |
| Oxycodone Hcl | 577 | $9,233 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 344 | $9,224 |
| Fentanyl | 81 | $9,045 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $8,868 |
| LinzessLinaclotide | 16 | $8,702 |
| Xtampza ErOxycodone Myristate | 24 | $8,435 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 59 | $7,712 |
| MovantikNaloxegol Oxalate | 16 | $6,340 |
| Pregabalin | 138 | $5,719 |
| Morphine Sulfate ErMorphine Sulfate | 190 | $5,516 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 271 | $4,222 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $393 | $30,29040 claims |
| PfizerNurtec Odt | $142 | $29,30422 claims |
| AbbVieLinzess | $489 | $8,70216 claims |
| Upsher-smith Laboratories LLCTopiramate | $43 | $4213 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 263 medical providers in Utah.
Other medical in Clinton
- Elisa WilcoxSalt Lake City$178K
- Val WarnerLayton$51K
- Viet leSalt Lake City$42K
- Carmelo DiazSalt Lake City$35K
- Shari CombeSalt Lake City$22K
- Kelly MikesellOgden$19K
- Jennifer CoombsSlc$12K
- Brandon HansenRiverton$10K
- Daniel CorryCedar City$10K
- Mark UdySt George$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.